HAIC Combined With Donafenib and Sintilimab for Unresectable ICC
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cholangiocarcinoma
Related studies linked through entity extraction aliases.
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand
- Status
- RECRUITING
- Phase
- NA
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
- Status
- COMPLETED
- Phase
- N/A
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- NA
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Registry for Advanced Endoscopy
- Status
- RECRUITING
- Phase
- N/A
Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis
- Status
- COMPLETED
- Phase
- PHASE2
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
- Status
- RECRUITING
- Phase
- N/A
Molecular Epidemiology of Biliary Tree Cancers
- Status
- RECRUITING
- Phase
- N/A
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- NA
Milademetan in Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
- Status
- COMPLETED
- Phase
- PHASE2